Tendai BbosaMedicine Access Strategy

The blog

Notes on medicine access.

Field notes on reimbursement pathways, frontline implementation, and closing the gap between regulatory approval and frontline implementation.

Latest writing01 article

Medicines Access · Canadian Health Systems
Approval Is Not Access: Why Canadian Patients Still Wait for Medicines After Regulatory Success
Regulatory approval is only one stage in the Canadian medicines access pathway. Why patients still wait after approval — and what closing the translation gap requires.
January 2025 · 8 min readRead article →

More on the way

New essays on access strategy are in progress. Get in touch to follow along.

Get in touch →